Physician profile
Mark Carlson
NPI 1790741049
$510.65
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $56.07 · 2021: $65.06 · 2022: $105.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $68.13 | 2019-2022 | |
| Radius Health, INC. | $55.75 | 2019 | |
| Trice Medical, INC. | $50.42 | 2019 | |
| Depuy Synthes Sales INC. | $45.93 | 2019 | |
| Bard Access Systems, INC. | $44.16 | 2019 | |
| Vericel Corporation | $40.79 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $38.93 | 2020 | |
| Orthofix Medical, INC. | $36.00 | 2022 | |
| Catalyst Orthoscience | $32.60 | 2019 | |
| Sonex Health, INC. | $24.25 | 2021 | |
| Smith+Nephew, INC. | $22.68 | 2021 | |
| Horizon Therapeutics Plc | $14.25 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $13.00 | 2022 | |
| Amniox Medical, INC. | $12.88 | 2019 | |
| Zyla Life Sciences, INC. | $10.88 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Carlson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.